The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Arcturus Therapeutics Ltd

Nasdaq: ARCT
Last

(U.S.) $8.87

Today's change+0.06 +0.74%
Updated November 21 2:54 PM -5GMT. Delayed by at least 15 minutes.
 

Arcturus Therapeutics Ltd

Nasdaq: ARCT
Last

(U.S.) $8.87

Today's change+0.06 +0.74%
Updated November 21 2:54 PM -5GMT. Delayed by at least 15 minutes.

Arcturus Therapeutics Ltd crosses above 50-day moving average

Arcturus Therapeutics Ltd is up today by (U.S.)$0.07 or 0.74% to (U.S.)$8.87 and crossing above its 50-day moving average. Over the last five days, shares have lost 9.54% and are down 39.69% for the last year to date. This security has underperformed the S&P 500 by 54.62% during the last year.

Key company metrics

  • Open(U.S.) $8.81
  • Previous close(U.S.) $8.80
  • High(U.S.) $9.15
  • Low(U.S.) $8.65
  • Bid / Ask(U.S.) $8.75 / (U.S.) $8.88
  • YTD % change-39.69%
  • Volume35,933
  • Average volume (10-day)64,860
  • Average volume (1-month)301,062
  • Average volume (3-month)116,618
  • 52-week range(U.S.) $5.81 to (U.S.) $18.04
  • Beta1.67
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$5.32
Updated November 21 2:54 PM -5GMT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense4468
Selling / general / administrative2111
Research & development1246
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income-4-4-6-8
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-4-6-8
Income after tax-4-4-6-8
Income tax, total0000
Net income-4-4-6-8
Total adjustments to net income--------
Net income before extra. items-4-4-6-8
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-4-6-8
Inc. avail. to common incl. extra. items-4-4-6-8
Diluted net income-4-4-6-8
Dilution adjustment--------
Diluted weighted average shares4444
Diluted EPS excluding extraordinary itemsvalue per share-0.94-0.89-1.51-1.98
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.94-0.89-1.51-1.98